Adipose-derived stem cell fate is predicted by cellular mechanical properties.
González-Cruz RD., Darling EM.
Laboratory Study, published in Adipocyte (2013) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Adipocyte (2013)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 23805404
- PMCID
- PMC3661107
- DOI
- 10.4161/adip.23015
- Citations
- 16
Abstract (original English)
Adipose-derived stem cells (ASCs) show great promise for tissue engineering applications and cell-based therapies because of their multipotency, relative abundance and immunosuppressive properties. However, ASCs must be isolated from heterogeneous cell populations present in adipose tissue. In this brief report, we provide a concise summary of the history and use of cellular mechanical properties as novel, label-free biomarkers to predict the differentiation potential of ASCs toward adipogenic, osteogenic and chondrogenic lineages. Additionally, we have found that passage number influences the mechanical properties of ASCs along with a discussion of potential environmental factors that could affect these properties. Altogether, this report provides evidence for the reliability of cellular mechanical properties as biomarkers for ASC differentiation potential and outlines how they can be used to sort ASCs with lineage-specific preferences for particular applications.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.